ACE-011
Showing 1 - 25 of 682
Beta Thalassemia Major, Beta Thalassemia Intermedia Trial in Worldwide (SOTATERCEPT (ACE-011))
Completed
- Beta Thalassemia Major
- Beta Thalassemia Intermedia
- SOTATERCEPT (ACE-011)
-
Créteil, France
- +14 more
Aug 18, 2022
Multiple Myeloma Trial in Atlanta, Boston (ACE-011, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- ACE-011
- +3 more
-
Atlanta, Georgia
- +3 more
Oct 28, 2021
Pulmonary Arterial Hypertension Trial (Sotatercept)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Sotatercept
- (no location specified)
Apr 5, 2023
Diamond Blackfan Anemia Trial in Manhasset (Sotatercept, Sotatercept with prednisone boost)
Terminated
- Diamond Blackfan Anemia
- Sotatercept
- Sotatercept with prednisone boost
-
Manhasset, New YorkNorth Shore- LIJ campus of The Feinstein Institute for Medical R
Nov 22, 2021
Pulmonary Arterial Hypertension Trial in Worldwide (Placebo, Sotatercept)
Completed
- Pulmonary Arterial Hypertension
- Placebo
- Sotatercept
-
Phoenix, Arizona
- +42 more
Jan 11, 2023
Myelodysplastic Syndrome Trial in Summit (ACE-011)
No longer available
- Myelodysplastic Syndrome
- ACE-011
-
Summit, New JerseyCelgene
Jul 16, 2020
Cpc-PH Due to HFpEF (Combined Post-capillary and Pre-capillary Pulmonary Hypertension Due to Heart Failure With Preserved
Recruiting
- Hypertension, Pulmonary
- Sotatercept 0.3 mg/kg
- +2 more
-
Phoenix, Arizona
- +68 more
Jan 20, 2023
Pulmonary Arterial Hypertension Trial in Worldwide (Sotatercept, Placebo)
Recruiting
- Pulmonary Arterial Hypertension
- Sotatercept
- Placebo
-
Los Angeles, California
- +39 more
Aug 5, 2022
Solid Tumors Trial in Baltimore, Philadelphia (ACE 011)
Terminated
- Solid Tumors
- ACE 011
-
Baltimore, Maryland
- +2 more
Oct 30, 2019
Multiple Myeloma Trial in Moscow, Saint-Petersburg (ACE-011, Placebo)
Completed
- Multiple Myeloma
- ACE-011
- Placebo
-
Moscow, Russian Federation
- +1 more
Oct 16, 2019
Pulmonary Arterial Hypertension Trial in Worldwide (Sotatercept, Placebo)
Recruiting
- Pulmonary Arterial Hypertension
- Sotatercept
- Placebo
-
Phoenix, Arizona
- +137 more
Jan 27, 2023
Chemo Induced Anemia Trial in Russian Federation, United States (Biological: ACE-011, Placebo)
Terminated
- Chemotherapy Induced Anemia
- Biological: ACE-011
- Placebo
-
Sedona, Arizona
- +38 more
Oct 16, 2019
Urothelial Carcinoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)
Active, not recruiting
- Urothelial Carcinoma
- Pembrolizumab
- +2 more
-
Gilbert, Arizona
- +193 more
Aug 22, 2022
Relapsed/Refractory Multiple Myeloma Trial in New York, Nashville, Salt Lake City (CB-011)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- CB-011
-
New York, New York
- +3 more
Feb 15, 2023
Non-muscle-invasive Bladder Cancer Trial in Myrtle Beach, Nashville (AU-011, AU-011 in Combination with Medical Laser)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- AU-011
- AU-011 in Combination with Medical Laser
-
Myrtle Beach, South Carolina
- +1 more
Jul 29, 2022
Breast Feeding, Hypertension, Heart Failure Trial in Leuven (Venipuncture)
Recruiting
- Breast Feeding
- +3 more
- Venipuncture
-
Leuven, Vlaams-Brabant, BelgiumUniversitaire Ziekenhuizen Leuven
Oct 12, 2023
Adolescent Behavior, Nutrition, Healthy Trial in Ithaca (ACE intervention)
Active, not recruiting
- Adolescent Behavior
- Nutrition, Healthy
- ACE intervention
-
Ithaca, New YorkCornell University
Jun 22, 2023
PAH Trial in Worldwide (sotatercept)
Recruiting
- Pulmonary Arterial Hypertension
- PAH
- Sotatercept
-
Phoenix, Arizona
- +167 more
Jan 27, 2023
Primary Indeterminate Lesions or Choroidal Melanoma
Recruiting
- Choroidal Melanoma
- Indeterminate Lesions of Eye
-
Tucson, Arizona
- +14 more
Dec 7, 2022